Daré Bioscience Inc.

NASDAQ: DARE · Real-Time Price · USD
2.19
0.12 (5.80%)
At close: Aug 15, 2025, 3:59 PM
2.20
0.69%
After-hours: Aug 15, 2025, 04:04 PM EDT

Daré Bioscience Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
9.78K 2.81M 10M n/a
Cost of Revenue
513.33K 38.36K 47.62K 26.41K
Gross Profit
-14.29M 2.77M 9.95M -26.41K
Operating Income
-23.45M -30.94M -31.39M -39.07M
Interest Income
n/a n/a n/a n/a
Pretax Income
-4.05M -30.16M -30.95M -38.7M
Net Income
-4.05M -30.16M -30.95M -38.33M
Selling & General & Admin
9.16M 12.11M 11.24M 8.35M
Research & Development
14.21M 21.54M 30.04M 30.62M
Other Expenses
100K 100K 100K n/a
Operating Expenses
23.46M 33.61M 41.38M 39.07M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
800K n/a n/a 561K
Cost & Expenses
23.46M 33.75M 41.38M 39.07M
Income Tax Expense
n/a n/a n/a -370K
Shares Outstanding (Basic)
8.5M 7.28M 7.05M 5.1M
Shares Outstanding (Diluted)
8.5M 7.28M 7.05M 5.1M
EPS (Basic)
-0.48 -4.15 -4.39 -7.52
EPS (Diluted)
-0.48 -4.15 -4.39 -7.52
EBITDA
-23.41M -30.9M -31.36M -39.04M
EBIT
-23.45M -30.74M -31.39M -39.07M
Depreciation & Amortization
42.33K 38.36K 24.2K 26.41K